Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

6.63
+0.58009.59%
Post-market: 6.640.0100+0.15%19:51 EDT
Volume:915.57K
Turnover:5.92M
Market Cap:359.86M
PE:-2.70
High:6.67
Open:6.17
Low:6.16
Close:6.05
Loading ...

Emergent BioSolutions Gets $65M Deal for Ontario Naloxone Program

Dow Jones
·
02 May

Emergent BioSolutions announces $65M agreement to provide Ontario with NARCAN

TIPRANKS
·
02 May

Emergent BioSolutions Inc - Signs $65 Million Agreement With Ontario Health

THOMSON REUTERS
·
02 May

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

GlobeNewswire
·
02 May

Envista Reports First Quarter 2025 Results

PR Newswire
·
02 May

Ethiopian police raids private news outlet over alleged violence-inciting documentary

CoinMarketCap
·
23 Apr

Institutional investors in Emergent BioSolutions Inc. (NYSE:EBS) see US$31m decrease in market cap last week, although long-term gains have benefitted them.

Simply Wall St.
·
11 Apr

Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?

Zacks
·
10 Apr

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple

Reuters
·
01 Apr

BUZZ-Emergent BioSolutions up after authorizing $50 million stock repurchase plan

Reuters
·
31 Mar

Emergent BioSolutions Shares Rise 13% After Co Authorizes $50 Mln Stock Repurchase Program

THOMSON REUTERS
·
31 Mar

Emergent BioSolutions Authorizes $50 Million Stock Buyback Program

MT Newswires Live
·
31 Mar

Emergent BioSolutions Shares Rise 3.2% Premarket After Co Authorizes $50 Mln Stock Repurchase Program

THOMSON REUTERS
·
31 Mar

Emergent BioSolutions Inc - Authorizes $50 Million Stock Repurchase Program

THOMSON REUTERS
·
31 Mar

Emergent BioSolutions Announces Stock Repurchase Program

THOMSON REUTERS
·
31 Mar

Emergent BioSolutions Announces Stock Repurchase Program

GlobeNewswire
·
31 Mar

DEXIS to Showcase Cutting-Edge Innovations at IDS 2025

ACCESS Newswire
·
24 Mar

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Mar

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

GlobeNewswire
·
21 Mar